General Information |
|
| NSE Symbol* | NEPHROCARE |
| Name of the Company* | NEPHRO CARE INDIA LIMITED |
| ISIN* | INE0SUN01013 |
| Type of Meeting |
1) Board Meeting 2) Committee Meeting |
| Details of Committee Meeting or Other Type of Meeting | Audit Committee |
| Type of Intimation* | New |
| Reason for Re-schedule (postpone or prepone) / Cancellation | |
| Proposed Meeting Date | 2025-05-28 |
| Original Meeting Date | |
| Whether trading window is closed* | Yes |
| Trading Window Closure- Start date | 2025-04-01 |
| Details of Trading Window Closure End date | 2025-05-30 |
| Short Notice | |
| Date of Report* | 2025-05-13 |
Agenda Details |
|
| Agenda* |
1) Financial results 2) Other business |
| Whether results are audited or unaudited | Audited |
| Nature of report standalone or consolidated | Standalone |
| Period end Type | Yearly |
| Period up to (Month) | March |
| Period up to (Year) | 2025 |
| Mode of raising Funds | |
| Type of Dividend | |
| Remarks (website dissemination) | Notice be and is hereby given to the members of Board of Directors of Nephro Care India Limited that a meeting of the Board of Directors of the Company will be held through Audio Visual Means (Video Conferencing Facility) on Wednesday, the 28th day of May 2025 at 2:00 P.M to transact the following businesses: 1. To elect the Chairman of the Meeting. 2. To grant leave of absence, if any. 3. To Confirm and sign the minutes of the last Board Meeting held on 12th day of February 2025. 4. Noting of Annual disclosure of all the director’s u/s 164 & 184 of the Companies Act 2013. 5. Noting of declaration of Independence from the Independent directors of the Company. 6. To Consider and Approve the Audited Standalone Financial Results of the Company along with Statement of Profit or loss and Cash Flow for the quarter and year ended 31st March 2025. 7. Noting of Statutory Auditors Report for the year ended 31st March 2025. 8. Noting of Internal Audit Report for the year ended 31st March 2025. 9. To authorize severally Dr. Pratim Sengupta, Managing Director, Mr. Sougata Sengupta, Company Secretary, and Mr. Buddha Das, Center in charge Business development of the Company, to do all such acts, deeds, and things as may be necessary and/or incidental for the implementation and execution of the Bandra Project, including submission, execution, signing of other documents, as may be required from time to time. 10. To take on record of Related Party Transaction(s) for the half year ended 31st March 2025 11. To take on Record CEO/CFO Certificate Under Regulation 17(8) of the Listing Regulations. 12. Opening of Bank Account with HDFC Bank in Mumbai for Bandra Project. 13. Authorised Dr. Pratim Sengupta, Managing Director, of the Company to execute, enter and do all the acts, deed and things as may be required for the Ranchi Nephrology Clinic Business Collaboration Agreement. 14. Formation of Sub Committee of Board named as Business Alliance & Growth Committee. 15. Any other matter as may be considered by the Chairman. |